{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:05:51Z","timestamp":1784531151086,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013784","name":"Fu Jen Catholic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119674","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:24:26Z","timestamp":1781886266000},"page":"119674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Administration of Pgk1 missense mutation leads to more effective mitigation of neurodegenerative effects observed in ALS mice and transgenic zebrafish"],"prefix":"10.1016","volume":"201","author":[{"given":"Bing-Chang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Che","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Zen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3932-3872","authenticated-orcid":false,"given":"Chun-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Hour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-4939","authenticated-orcid":false,"given":"Huai-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119674_bib1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41576-023-00592-y","article-title":"Amyotrophic lateral sclerosis: translating genetic discoveries into therapies","volume":"24","author":"Ak\u00e7imen","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2026.119674_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119674_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ajmg.1320510114","article-title":"Genetic linkage analysis of familial amyotrophic lateral sclerosis using human chromosome 21 microsatellite DNA markers","volume":"51","author":"Rosen","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.biopha.2026.119674_bib4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI71601","article-title":"Emerging mechanisms of molecular pathology in ALS","volume":"125","author":"Peters","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119674_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00401-015-1436-x","article-title":"Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease","volume":"130","author":"Pottier","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119674_bib6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.biopha.2026.119674_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119674_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/jpm10030101","article-title":"Molecular and cellular mechanisms affected in ALS","volume":"10","author":"Le Gall","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.biopha.2026.119674_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119674_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neures.2017.09.011","article-title":"The multi-dimensional roles of astrocytes in ALS","volume":"126","author":"Yamanaka","year":"2018","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.biopha.2026.119674_bib11","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.biopha.2026.119674_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","article-title":"Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis","volume":"18","author":"Sawada","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119674_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate\u2013taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119674_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.27091","article-title":"Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis","volume":"63","author":"Paganoni","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.biopha.2026.119674_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/13547500903056051","article-title":"Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients","volume":"14","author":"Harel","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.biopha.2026.119674_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.21122","article-title":"Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes","volume":"62","author":"Pradat","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119674_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/nbdi.2002.0522","article-title":"Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119674_bib18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.embor.7400826","article-title":"The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model","volume":"7","author":"Jokic","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2026.119674_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/acn3.179","article-title":"Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients","volume":"2","author":"Bruneteau","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2026.119674_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(16)30399-4","article-title":"NOG112264 Study Group, Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Meininger","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119674_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49175","article-title":"Extracellular Pgk1 enhances neurite outgrowth of motoneurons through Nogo66\/NgR-independent targeting of NogoA","volume":"8","author":"Lin","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2026.119674_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s42003-023-05223-0","article-title":"Extracellular Pgk1 interacts neural membrane protein enolase-2 to improve the neurite outgrowth of motor neurons","volume":"6","author":"Fu","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2026.119674_bib23","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.3390\/ijms251910753","article-title":"The 419th aspartic acid of neural membrane protein enolase 2 is a key residue involved in the axonal growth of motor neurons mediated by interaction between enolase 2 receptor and extracellular Pgk1 ligand","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119674_bib24","first-page":"209","article-title":"Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev. Dyn. Off. Publ. Am. Assoc. Anat."},{"key":"10.1016\/j.biopha.2026.119674_bib25","first-page":"4471","article-title":"Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations","volume":"132","author":"Flanagan-Steet","year":"2005","journal-title":"Dev. Camb. Engl."},{"key":"10.1016\/j.biopha.2026.119674_bib26","series-title":"The Zebrafish Book: A guide for the laboratory use of zebrafish (Danio rerio)","author":"Westerfield","year":"1995"},{"key":"10.1016\/j.biopha.2026.119674_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/elps.1150080203","article-title":"Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels","volume":"8","author":"Blum","year":"1987","journal-title":"Electrophoresis"},{"key":"10.1016\/j.biopha.2026.119674_bib28","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4215","article-title":"Whole-mount staining of mouse diaphragm neuromuscular junctions","volume":"11","author":"Sha","year":"2021","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.biopha.2026.119674_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nbd.2018.12.002","article-title":"Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS","volume":"124","author":"Sengupta-Ghosh","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119674_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89298.4","article-title":"EphrinB2 knockdown in cervical spinal cord preserves diaphragm innervation in a mutant SOD1 mouse model of ALS","volume":"12","author":"Urban","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2026.119674_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10126-018-9857-x","article-title":"Conditional overexpression of rtn4al in muscle of adult zebrafish displays defects similar to human amyotrophic lateral sclerosis","volume":"21","author":"Lin","year":"2019","journal-title":"Mar. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119674_bib32","doi-asserted-by":"crossref","DOI":"10.3791\/55226","article-title":"Hydraulic extrusion of the spinal cord and isolation of dorsal root ganglia in rodents","author":"Richner","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2026.119674_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/laban0108-26","article-title":"Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model","volume":"37","author":"Steel","year":"2008","journal-title":"Lab. Anim."},{"key":"10.1016\/j.biopha.2026.119674_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.physbeh.2013.11.010","article-title":"Relationships between tongue motility, grip force, and survival in SOD1-G93A rats","volume":"125","author":"Smittkamp","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2026.119674_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-024-00349-z","article-title":"AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice","volume":"14","author":"Chen","year":"2024","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.biopha.2026.119674_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119674_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119674_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting modern challenges in visualization and analysis: UCSF ChimeraX Visualization System","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.biopha.2026.119674_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease","volume":"8","author":"Moloney","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2026.119674_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-7-44","article-title":"Neuromuscular effects of G93A-SOD1 expression in zebrafish","volume":"7","author":"Sakowski","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2026.119674_bib41","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0149-2918(02)80075-3","article-title":"Immunogenicity of therapeutic proteins: Clinical implications and future prospects","volume":"24","author":"Schellekens","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2026.119674_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00005072-198111000-00008","article-title":"Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis","volume":"40","author":"Kawamura","year":"1981","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119674_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2007.07.003","article-title":"Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"28","author":"Hegedus","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119674_bib44","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119674_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119674_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41973","article-title":"Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS","volume":"7","author":"Martineau","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2026.119674_bib47","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119674_bib48","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.3390\/ijms24109022","article-title":"Early alterations in structural and functional properties in the neuromuscular junctions of mutant FUS mice","volume":"24","author":"Mukhamedyarov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119674_bib49","first-page":"113","article-title":"Breathing: Motor Control of Diaphragm Muscle","volume":"33","author":"Fogarty","year":"2018","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.biopha.2026.119674_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1742-2094-11-55","article-title":"Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase","volume":"11","author":"Lewis","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.119674_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2005.12.003","article-title":"Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study","volume":"244","author":"Stephens","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2026.119674_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119674_bib53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Abe","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119674_bib54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","article-title":"Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis","volume":"29","author":"Wang","year":"2022","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119674_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119674_bib56","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119674_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678421.2019.1632346","article-title":"on behalf of the AB10015 STUDY GROUP, Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"21","author":"Mora","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:38:58Z","timestamp":1784529538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S0753332226007109"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119674","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of Pgk1 missense mutation leads to more effective mitigation of neurodegenerative effects observed in ALS mice and transgenic zebrafish","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119674"}}